Orion Integrated Biosciences Inc.
Willy A. Valdivia is the founder and Chief Executive Officer of Orion Integrated Biosciences Inc., a position held since November 2003. Additionally, Willy A. Valdivia serves as a Scientific Advisor at AgroSpheres and as an Adjunct Faculty Member at Kansas State University College of Veterinary Medicine, both roles assumed in 2020. Previously, Willy A. Valdivia worked as a Subject Matter Expert for the European Commission from January 2018 to December 2020, where responsibilities included establishing frameworks for capability assessments and contributing to risk-informed analysis methodologies. Earlier experience includes research in bioinformatics and genomics at North Dakota State University, a role as a Visiting Scientist in molecular biology at the International Potato Center, and a Research Associate position at the Peruvian Institute of Nuclear Energy focused on developing a neutron irradiation facility for plant breeding.
This person is not in any teams
This person is not in any offices
Orion Integrated Biosciences Inc.
Background: Pathogens continue to rampage global health, causing more than fifteen million deaths and producing a significant economic loss. These infections take many forms, from the mild and debilitating common cold, which kills millions of people every year, to the violently fatal hemorrhagic fevers caused by the Ebola virus, which has a 90% lethality rate in humans. Outbreaks of SARS, H1N5 avian, and H1N1 pandemic influenzas have demonstrated that we remain unprepared to respond to the impact of emerging pathogens. The contagiousness and virulence of more than eighty other microbes have raised concerns about the possibility of their intentional use to harm humans, livestock, and crops. These problems are complicated, and the increasing levels of drug resistance show no signs of abating. Mission: Orion Integrated Biosciences Inc. provides solutions for complex biological problems affecting global health and the environment. Objectives: Orion Integrated Biosciences Inc. is committed to bringing the best scientific minds to accomplish three main goals: 1) Address the increasing demand for new surveillance and detection devices that are capable of recognizing known and unknown pathogens. 2) Develop a new generation of antimicrobials (small molecules and biologicals) to inhibit infections. 3) Produce a new generation of rationally designed vaccines.